These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 12182087

  • 1. Iatrogenesis imperfecta.
    Friedman JH.
    Med Health R I; 2002 Jul; 85(7):198. PubMed ID: 12182087
    [No Abstract] [Full Text] [Related]

  • 2. [The treatment of Parkinson disease].
    Jiménez-Jiménez FJ.
    Med Clin (Barc); 1999 Feb 27; 112(7):257-8. PubMed ID: 10220753
    [No Abstract] [Full Text] [Related]

  • 3. [Depressive syndrome, psychoses, dementia: frequent manifestations in Parkinson disease].
    Wedekind S.
    MMW Fortschr Med; 2005 Jun 02; 147(22):11. PubMed ID: 15977623
    [No Abstract] [Full Text] [Related]

  • 4. Dopaminergic psychosis in advanced Parkinson's disease.
    Fischer P, Danielczyk W, Simanyi M, Streifler MB.
    Adv Neurol; 1990 Jun 02; 53():391-7. PubMed ID: 2122647
    [No Abstract] [Full Text] [Related]

  • 5. [Psychosis due to the interaction of erythromycin and bromocriptine in Parkinson disease].
    Alegre M, Noé E, Martínez Lage JM.
    Neurologia; 1997 Nov 02; 12(9):429. PubMed ID: 9471184
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Drug-induced psychosis in Parkinson disease: phenomenology and correlations among psychosis rating instruments.
    Papapetropoulos S.
    Clin Neuropharmacol; 2006 Nov 02; 29(1):59. PubMed ID: 16518136
    [No Abstract] [Full Text] [Related]

  • 13. Parkinson's disease.
    Clarke C, Moore AP.
    Clin Evid; 2002 Jun 02; (7):1208-20. PubMed ID: 12230738
    [No Abstract] [Full Text] [Related]

  • 14. Treatment challenges in early stage Parkinson's disease.
    Tetrud J.
    Neurol Clin; 2004 Oct 02; 22(3 Suppl):S19-33. PubMed ID: 15501364
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Parkinson's disease.
    Clarke C, Moore A.
    Clin Evid; 2002 Dec 02; (8):1370-85. PubMed ID: 12603943
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Long-term follow-up (24 months) of quetiapine treatment in drug-induced Parkinson disease psychosis.
    Klein C, Prokhorov T, Miniovich A, Dobronevsky E, Rabey JM.
    Clin Neuropharmacol; 2006 Dec 02; 29(4):215-9. PubMed ID: 16855423
    [Abstract] [Full Text] [Related]

  • 19. [Treatment of later phases of Parkinson disease].
    Tison F.
    Rev Neurol (Paris); 2008 Apr 02; 164 Spec No 2():F85-8. PubMed ID: 18680823
    [No Abstract] [Full Text] [Related]

  • 20. What we have learned about sleep disorders and psychosis after nearly two centuries of Parkinson's disease. Summary and conclusions.
    Fernandez HH.
    CNS Spectr; 2008 Mar 02; 13(3 Suppl 4):34-5. PubMed ID: 18323765
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.